Comparative Pharmacology
Head-to-head clinical analysis: PROSOM versus RESTORIL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROSOM versus RESTORIL.
PROSOM vs RESTORIL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
GABAA receptor agonist, potentiates GABAergic inhibition
Temazepam is a benzodiazepine that enhances the effect of gamma-aminobutyric acid (GABA) at the GABA-A receptor, leading to increased chloride ion influx and hyperpolarization of the postsynaptic neuron, resulting in sedation and anxiolysis.
0.5 mg orally once daily at bedtime for insomnia; maximum dose 1 mg.
Oral: 15-30 mg once daily at bedtime, as needed for insomnia. Maximum dose: 30 mg/day.
None Documented
None Documented
Terminal elimination half-life is approximately 20–30 hours (mean 25 h) in adults. Clinically, this supports once-daily dosing with potential for accumulation with repeated administration.
Terminal elimination half-life is approximately 10-15 hours in healthy adults. Clinical context: Half-life may be prolonged in elderly patients and those with hepatic impairment; accumulation may occur with repeated dosing, leading to prolonged sedation.
Renal: 80% as metabolites, primarily conjugated; unchanged drug <1%. Fecal: 15%. Biliary: minor.
Renal (approximately 80% as conjugated metabolites, less than 2% unchanged); fecal (approximately 20%).
Category C
Category C
Benzodiazepine Hypnotic
Benzodiazepine Hypnotic